Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.